ADHD(注意欠陥・多動性障害)治療薬の世界市場:市場インサイト、疫学、市場予測

◆英語タイトル:Attention-deficit/hyperactivity disorder (ADHD)- Market Insights, Epidemiology and Market Forecast-2023
◆商品コード:DLVEP06128
◆発行会社(調査会社):DelveInsight
◆発行日:2016年8月
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後10営業日)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD9,900 ⇒換算¥1,128,600見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD14,850 ⇒換算¥1,692,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規販売代理店です。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、ADHD(注意欠陥・多動性障害)治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。
・ADHD(注意欠陥・多動性障害)の概要
・病態生理
・ADHD(注意欠陥・多動性障害)の症状
・ADHD(注意欠陥・多動性障害)の病因
・ADHD(注意欠陥・多動性障害)の診断
・ADHD(注意欠陥・多動性障害)の治療
・上市品の概要
・医薬品の説明
・作用機序
・薬物動態学的特性
・特許情報
・ADHD(注意欠陥・多動性障害)の疫学分析
・ADHD(注意欠陥・多動性障害)治療薬の世界市場規模
・ADHD(注意欠陥・多動性障害)治療薬の世界市場予測
・ADHD(注意欠陥・多動性障害)治療薬のアメリカ市場規模
・ADHD(注意欠陥・多動性障害)治療薬のアメリカ市場予測
・ADHD(注意欠陥・多動性障害)治療薬のヨーロッパ市場規模
・ADHD(注意欠陥・多動性障害)治療薬のヨーロッパ市場予測
(ドイツ、イギリス、フランス、イタリア、スペイン)
・ADHD(注意欠陥・多動性障害)治療薬の日本市場規模
・ADHD(注意欠陥・多動性障害)治療薬の日本市場予測
【レポートの概要】

Note*: This report requires 7-10 business days to complete.
DelveInsight’s Attention-deficit/hyperactivity disorder (ADHD) – Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Attention-deficit/hyperactivity disorder (ADHD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Attention-deficit/hyperactivity disorder (ADHD) till 2023.

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Attention-deficit/hyperactivity disorder (ADHD) market.
• Identifying patient populations in the global “Attention-deficit/hyperactivity disorder (ADHD)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Attention-deficit/hyperactivity disorder (ADHD) therapeutics in each of the markets covered.
• To understand the future market competition in the global Attention-deficit/hyperactivity disorder (ADHD) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Attention-deficit/hyperactivity disorder (ADHD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

【レポートの目次】

Table of Contents

• Attention-deficit/hyperactivity disorder (ADHD) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Attention-deficit/hyperactivity disorder (ADHD) Market
• Global Epidemiology of Attention-deficit/hyperactivity disorder (ADHD) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight

List of Tables

• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Attention-deficit/hyperactivity disorder (ADHD) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Attention-deficit/hyperactivity disorder (ADHD) (2013-2023)
• Table 7: Attention-deficit/hyperactivity disorder (ADHD) Global Market (USD Millions), (2013-2015)
• Table 8: Attention-deficit/hyperactivity disorder (ADHD) Global Market (USD Millions), (2016-2023)
• Table 9: Attention-deficit/hyperactivity disorder (ADHD) US Market (USD Millions), (2013-2015)
• Table 10: Attention-deficit/hyperactivity disorder (ADHD) US Market (USD Millions), (2016-2023)
• Table 11: Attention-deficit/hyperactivity disorder (ADHD) Germany Market (USD Millions), (2013-2015)
• Table 12: Attention-deficit/hyperactivity disorder (ADHD) Germany Market (USD Millions), (2016-2023)
• Table 13: Attention-deficit/hyperactivity disorder (ADHD) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Attention-deficit/hyperactivity disorder (ADHD) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Attention-deficit/hyperactivity disorder (ADHD) France Market (USD Millions), (2013-2015)
• Table 16: Attention-deficit/hyperactivity disorder (ADHD) France Market (USD Millions), (2016-2023)
• Table 17: Attention-deficit/hyperactivity disorder (ADHD) Italy Market (USD Millions), (2013-2015)
• Table 18: Attention-deficit/hyperactivity disorder (ADHD) Italy Market (USD Millions), (2016-2023)
• Table 19: Attention-deficit/hyperactivity disorder (ADHD) Spain Market (USD Millions), (2013-2015)
• Table 20: Attention-deficit/hyperactivity disorder (ADHD) Spain Market (USD Millions), (2016-2023)
• Table 21: Attention-deficit/hyperactivity disorder (ADHD) Japan Market (USD Millions), (2013-2015)
• Table 22: Attention-deficit/hyperactivity disorder (ADHD) Japan Market (USD Millions), (2016-2023)
• Table 23: Attention-deficit/hyperactivity disorder (ADHD) ROW Market (USD Millions), (2013-2015)
• Table 24: Attention-deficit/hyperactivity disorder (ADHD) ROW Market (USD Millions), (2016-2023)

List of Figures

• Figure 1: Attention-deficit/hyperactivity disorder (ADHD) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Attention-deficit/hyperactivity disorder (ADHD) (2013-2023)
• Figure 3: Attention-deficit/hyperactivity disorder (ADHD) Global Market (USD Millions), (2013-2015)
• Figure 4: Attention-deficit/hyperactivity disorder (ADHD) Global Market (USD Millions), (2016-2023)
• Figure 5: Attention-deficit/hyperactivity disorder (ADHD) US Market (USD Millions), (2013-2015)
• Figure 6: Attention-deficit/hyperactivity disorder (ADHD) US Market (USD Millions), (2016-2023)
• Figure 7: Attention-deficit/hyperactivity disorder (ADHD) Germany Market (USD Millions), (2013-2015)
• Figure 8: Attention-deficit/hyperactivity disorder (ADHD) Germany Market (USD Millions), (2016-2023)
• Figure 9: Attention-deficit/hyperactivity disorder (ADHD) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Attention-deficit/hyperactivity disorder (ADHD) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Attention-deficit/hyperactivity disorder (ADHD) France Market (USD Millions), (2013-2015)
• Figure 12: Attention-deficit/hyperactivity disorder (ADHD) France Market (USD Millions), (2016-2023)
• Figure 13: Attention-deficit/hyperactivity disorder (ADHD) Italy Market (USD Millions), (2013-2015)
• Figure 14: Attention-deficit/hyperactivity disorder (ADHD) Italy Market (USD Millions), (2016-2023)
• Figure 15: Attention-deficit/hyperactivity disorder (ADHD) Spain Market (USD Millions), (2013-2015)
• Figure 16: Attention-deficit/hyperactivity disorder (ADHD) Spain Market (USD Millions), (2016-2023)
• Figure 17: Attention-deficit/hyperactivity disorder (ADHD) Japan Market (USD Millions), (2013-2015)
• Figure 18: Attention-deficit/hyperactivity disorder (ADHD) Japan Market (USD Millions), (2015-2023)
• Figure 19: Attention-deficit/hyperactivity disorder (ADHD) ROW Market (USD Millions), (2013-2015)
• Figure 20: Attention-deficit/hyperactivity disorder (ADHD) ROW Market (USD Millions), (2016-2023)



【掲載企業】

• Shire Plc
• Eli Lilly and Company
• Johnson & Johnson
• Novartis AG
• QPS Holdings LLC
• Supernus Pharmaceuticals Inc.
• Neos Therapeutics Inc.
• Highland Therapeutics Inc.
• Altasciences Company Inc
• Alcobra Ltd

【レポートのキーワード】

ADHD(注意欠陥・多動性障害)

★調査レポート[ADHD(注意欠陥・多動性障害)治療薬の世界市場:市場インサイト、疫学、市場予測]販売に関する免責事項
★調査レポート[ADHD(注意欠陥・多動性障害)治療薬の世界市場:市場インサイト、疫学、市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆